Consensus eHealth, Inc.

Equities

EHTH

US28238P1093

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-22 pm EDT			5-day change	1st Jan Change
4.55 ^USD	+1.34%		+5.57%	-47.82%

Apr. 18	EHealth Reaffirms 2024 Guidance	MT
Apr. 15	Adherium’s Hailie Smartinhaler Secures FDA Approval for Use with AstraZeneca's Airsupra and Breztri Inhalation Devices	MT

Evolution of the average Target Price on eHealth, Inc.

Price target over the last 5 years

History of analyst recommendation changes

87a6b5c1f64b4e591adea58.FkrOi04s_CLyWzKCVbeI_p8g6DoIBd5ttALiz04VDa0.ZC2e5ycbkmSTHHHmN87RjNp0vG9ec5Ve8EiOjTlUSv9gKaPqAmGteoJqZw~4578ca5fd3d87894fa15cce0b4249954

Analyst Recommendations on eHealth, Inc.

Deutsche Bank Adjusts eHealth Price Target to $5 From $8, Maintains Hold Rating	Feb. 28	MT
Craig-Hallum Downgrades eHealth to Hold From Buy, Cuts Price Target to $7 From $11	Jan. 18	MT
Deutsche Bank Adjusts eHealth Price Target to $8 From $10, Maintains Hold Rating	Nov. 10	MT
Deutsche Bank Adjusts eHealth Price Target to $10 From $5, Maintains Hold Rating	23-08-09	MT
Citigroup Adjusts eHealth's Price Target to $9 From $7, Keeps Neutral Rating	23-05-12	MT
Citigroup Adjusts eHealth's Price Target to $7 From $10, Keeps Neutral Rating	23-04-28	MT
Citigroup Adjusts Price Target on eHealth to $10 From $4.50, Maintains Neutral Rating	23-03-08	MT
Credit Suisse Raises eHealth's Price Target to $10 From $4, Says Concerns on Liquidity, Business Model Subside; Keeps Neutral Rating	23-03-06	MT
RBC Cuts Price Target on eHealth to $13 From $16, Maintains Sector Perform Rating	23-03-06	MT
Deutsche Bank Raises eHealth's Price Target to $5 From $4, Maintains Hold Rating	23-03-01	MT
Credit Suisse Lowers eHealth's Price Target to $4 From $10, Maintains Neutral Rating	22-11-23	MT
Deutsche Bank Adjusts eHealth Price Target to $4 From $10, Maintains Hold Rating	22-11-09	MT
Credit Suisse Lowers eHealth's PT to $10 from $13, Reduces Sales Estimates As Company Takes Prudent Approach to Spending; Maintains Neutral Rating	22-08-15	MT
Truist Lowers eHealth's Price Target to $8 From $12, Maintains Hold Rating	22-08-09	MT
Citigroup Adjusts eHealth's Price Target to $9 From $13, Maintains Neutral Rating	22-08-09	MT
Deutsche Bank Adjusts eHealth Price Target to $10 From $19, Maintains Hold Rating	22-05-05	MT
Credit Suisse Lowers eHealth's Price Target to $13 from $16 After Relatively In Line Q1 Results, Lowers 2022, 2023 Revenue Estimates; Keeps Neutral Rating	22-05-04	MT
Citigroup Downgrades EHealth to Neutral From Buy, Adjusts Price Target to $15 From $37	22-03-21	MT
RBC Cuts Price Target on EHealth to $17 From $28 After Q4 Results, 2022 Guidance Miss Expectations; Sector Perform Kept	22-03-14	MT
Credit Suisse Lowers eHealth's Price Target to $16 from $31 After Lower-than-Consensus Q4 Results, Keeps Neutral Rating	22-03-03	MT
Truist Securities Downgrades eHealth to Hold from Buy, Adjusts Price Target to $15 From $40	22-03-02	MT
Evercore ISI Cuts EHealth to In-Line From Outperform, Price Target to $15 From $35	22-03-02	MT
Barclays Downgrades eHealth to Equalweight from Overweight, Adjusts Price Target to $22 from $45	22-01-18	MT
Credit Suisse Downgrades eHealth to Neutral from Outperform, Says Among Potential M&A Targets; Lowers PT to $31 from $45	22-01-07	MT
Citigroup Adjusts eHealth's Price Target to $37 from $45, Keeps Buy Rating	21-12-20	MT